Peptides by Health Condition

Leaky gut (intestinal hyperpermeability) occurs when tight junctions between intestinal epithelial cells become compromised, allowing bacteria, toxins, and undigested food particles to enter the bloodstream. It is associated with IBD, IBS, autoimmune conditions, and systemic inflammation.

Joint pain can result from osteoarthritis (cartilage degradation), inflammatory arthritis (rheumatoid, psoriatic), tendinopathy, bursitis, or acute injury. Conventional treatments focus on symptom management; peptides may address underlying tissue repair mechanisms.

Low testosterone (hypogonadism) can be primary (testicular failure) or secondary (hypothalamic-pituitary dysfunction). Symptoms include fatigue, low libido, muscle loss, fat gain, depression, and cognitive decline. Peptides can support testosterone production through the HPG axis.

Male hypogonadism involves insufficient testosterone production due to testicular failure (primary) or hypothalamic-pituitary dysfunction (secondary). Symptoms include reduced libido, erectile dysfunction, fatigue, muscle loss, fat gain, mood changes, and reduced bone density.

Anxiety disorders include generalized anxiety disorder (GAD), social anxiety, panic disorder, and PTSD. They involve dysregulation of the stress response, GABAergic and serotonergic systems, and HPA axis. Peptides offer novel mechanisms distinct from conventional anxiolytics.

Anxiety disorders encompass generalized anxiety disorder (GAD), social anxiety, panic disorder, and PTSD. They involve dysregulation of the HPA axis, GABAergic and serotonergic neurotransmission, and neuroinflammation. Standard treatments include SSRIs, SNRIs, benzodiazepines, and cognitive behavioral therapy.

Major depressive disorder (MDD) involves persistent low mood, anhedonia, cognitive impairment, and neurobiological changes including reduced neuroplasticity, HPA axis dysregulation, and neuroinflammation. Standard treatments include SSRIs, SNRIs, tricyclics, MAOIs, and psychotherapy.

Poor sleep can result from insomnia, sleep apnea, circadian rhythm disruption, anxiety, or hormonal imbalances. Chronic poor sleep is associated with increased risk of cardiovascular disease, metabolic disorders, and cognitive decline. Peptides offer novel approaches to sleep quality improvement.

Tendinopathy encompasses a spectrum of tendon disorders including tendinitis (acute inflammation) and tendinosis (chronic degeneration). Common sites include the Achilles, patellar, rotator cuff, and lateral epicondyle tendons. Standard treatment includes rest, physical therapy, NSAIDs, and corticosteroid injections — but outcomes are often incomplete, driving interest in regenerative approaches.

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness characterized by profound fatigue not relieved by rest, post-exertional malaise, cognitive impairment, and sleep disturbances. The pathophysiology involves mitochondrial dysfunction, immune dysregulation, autonomic nervous system abnormalities, and neuroinflammation.

Osteoporosis is characterized by reduced bone mineral density (BMD) and deterioration of bone microarchitecture, increasing fracture risk. It results from an imbalance between osteoblast (bone formation) and osteoclast (bone resorption) activity. Standard treatments include bisphosphonates, denosumab, teriparatide (PTH analogue), and calcium/vitamin D supplementation.

Erectile dysfunction (ED) involves the inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It has vascular (endothelial dysfunction), neurological, hormonal (low testosterone), and psychological components. Standard treatments include PDE5 inhibitors (sildenafil, tadalafil), testosterone replacement, and vacuum erection devices.

Androgenetic alopecia (AGA) is the most common form of hair loss, driven by DHT (dihydrotestosterone) sensitivity in genetically predisposed hair follicles. It causes progressive miniaturization of hair follicles. Standard treatments include minoxidil, finasteride, and hair transplantation.

Skin aging involves both intrinsic (chronological) and extrinsic (photoaging) processes. Key changes include collagen loss (1% per year after age 20), reduced elastin, decreased hyaluronic acid, thinning of the dermis, and impaired wound healing. These changes result in wrinkles, laxity, uneven pigmentation, and reduced skin barrier function.

Obesity is a chronic metabolic disease characterized by excess adipose tissue accumulation that impairs health. It involves complex interactions between genetic predisposition, hormonal dysregulation (leptin resistance, insulin resistance), gut microbiome, and environmental factors. It significantly increases risk of type 2 diabetes, cardiovascular disease, and certain cancers.

Type 2 diabetes is characterized by insulin resistance and progressive beta-cell dysfunction, resulting in chronic hyperglycemia. It is driven by obesity, physical inactivity, and genetic factors. Complications include cardiovascular disease, nephropathy, retinopathy, and neuropathy.

Cognitive decline encompasses a spectrum from age-associated memory impairment to mild cognitive impairment (MCI) and Alzheimer's disease. Key mechanisms include neuroinflammation, mitochondrial dysfunction, reduced neuroplasticity (BDNF decline), amyloid accumulation, and tau pathology.

Impaired wound healing occurs when the normal healing cascade (hemostasis, inflammation, proliferation, remodeling) is disrupted. Common causes include diabetes, peripheral vascular disease, immunosuppression, malnutrition, and advanced age. Chronic wounds (diabetic ulcers, venous leg ulcers, pressure injuries) represent a significant healthcare burden.

Autoimmune diseases occur when the immune system attacks the body's own tissues. Common conditions include rheumatoid arthritis, lupus, multiple sclerosis, Hashimoto's thyroiditis, and inflammatory bowel disease. They involve dysregulated T-cell and B-cell activity, inflammatory cytokine overproduction, and loss of immune tolerance.

Insomnia is characterized by difficulty initiating or maintaining sleep, or non-restorative sleep, causing daytime impairment. It involves dysregulation of the sleep-wake cycle, HPA axis hyperactivation, and disrupted circadian rhythms. Chronic insomnia is associated with cardiovascular disease, metabolic disorders, and mental health conditions.